Strategic Roadmaps that go further.

Konexis doesn’t just improve communication, collaboration and visibility across your organisation. Our transformation roadmaps go further by driving meaningful change that shape your business transformation.

Deliver a roadmap
your audience understands

Building an interactive transformation roadmap had never been possible, unless you had a deep understanding of graphic design principles. But now, you can easily create and share your roadmaps in a format easily understood by your audience.

Build consensus
quickly

Equip yourself with the means to effectively communicate your strategic projects and initiatives to senior executives. Konexis facilitates collaborative decision-making and drives consensus by providing a clear and comprehensive view of your strategic initiatives through a visually engaging platform.

Save time
and money

A user-friendly interface and feature set will save you time and boost your efficiency, generating an instant ROI, as anyone can build a comprehensive strategic roadmap in a matter of minutes. With consistency across all your roadmaps too, you can spend more time delivering on your goals.

Replace manual tools such as PowerPoint and Excel

While versatile, PowerPoint and Excel are not built for strategic communication. Konexis is quicker and easier to use than both, giving you a more comprehensive roadmap that will help you work more collaboratively and communicate more effectively.

Easy creation
and maintenance

Transformation roadmaps can be hard to create and manage when data constantly changes, but Konexis makes it easy to update and maintain your roadmap. This aids version control, ensuring you always have the latest data to hand.

Improve visibility
across your organisation

Ensure that every team member understands your organisation’s strategic direction and their role within it.

Schedule a demo

Experience the difference Konexis can make to your strategic roadmap communication. Get started and try our roadmap tool for free with a one month trial.